Liver transplantation for hepatocellular carcinoma: racial disparities?
Liver transplantation for patients with early-stage hepatocellular cancer evidently represents an extremely effective treatment as compared to other modalities, at least by one analysis of a cancer database. However, less than one-fourth of the apparently acceptable candidates receive this treatment and African Americans are underrepresented in this group. The cause of these results, however, remains obscure with the need for a more in-depth confirmation of these findings readily apparent.
Freeman
Richard B
RB
D006528:Carcinoma, Hepatocellular / Q000208:ethnology / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000208:ethnology / Q000601:surgery*; D016031:Liver Transplantation / Q000208:ethnology* / Q000706:statistics & numerical data; D044469:Racial Groups; D018426:SEER Program; D014481:United States / Q000453:epidemiology